Stefan Leucht, MD

  • 20Articles
  • 61.4KReads
  • 2002–2024Active
  • 46Collaborators
  • 200Citations

About

Stefan Leucht, MD, is affiliated with the Department of Psychiatry and Psychotherapy at the TUM School of Medicine and Health, Technical University of Munich, Germany. Since 2002, Leucht has contributed to research on schizophrenia, schizoaffective disorders, psychiatry, neurology, and sexual dysfunction. Leucht has co-authored extensively with John M. Kane, Werner Kissling, Daniel Carpenter, Johannes Hamann, and John P. Docherty.

Publications

JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Narrative Review

Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia

August 19, 2024

While the pathophysiology of schizophrenia is complex, treatments with novel pharmacological actions that target these systems are of interest as adjunctive treatment for schizophrenia.
, , , et al
JCP
Generalizability of RCTs in First-Episode Schizophrenia
Original Research

Generalizability of RCTs in First-Episode Schizophrenia

March 29, 2023

First-episode schizophrenia patients with suicidal ideation and substance use disorder are often excluded from clinical trials. Omitting them does not affect key outcome measures but excludes many potential subjects.
, , , et al
JCP
Educational Activity

Measuring Outcomes in Schizophrenia and Examining Their Clinical Application

June 15, 2014

JCP
Supplement Article

Measurements of Response, Remission, and Recovery in Schizophrenia and Examples for Their Clinical Application

February 21, 2014

JCP
Original Research

Antipsychotic Medications & Schizophrenia

December 15, 2011

Explore an analysis on Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia.
, , , et al
JCP
Letter to the Editor

Reply to The Importance of Negative Comorbidity

August 15, 2009

,
JCP
Original Research

Comorbid Somatic Illnesses in Patients With Severe Mental Disorders: Clinical, Policy, and Research Challenges

March 18, 2008

, , , et al
JCP
Letter to the Editor

Dr. Hamann and Colleagues Reply

February 14, 2008

, ,
JCP
Original Research

Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment

July 16, 2007

, , , et al
JCP
Academic Highlights

New Developments in the Treatment of Schizophrenia.

March 15, 2007

, , , et al
JCP
Original Research

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia.

March 15, 2007

, , , et al
JCP
Original Research

Attitudes of Psychiatrists Toward Antipsychotic Depot Medication

December 15, 2006

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe